Frèdèrique Menzaghi
Net worth: 152 195 $ as of 2024-03-30
Profile
Frèdèrique Menzaghi is the founder of CARA Therapeutics, Inc. founded in 2004, where she held the title of Chief Scientific Officer and Senior VP-R&D until 2024.
She is also the founder of Sibia Neurosciences, Inc. Dr. Menzaghi's former jobs include Director-In Vivo Pharmacology at Arena Pharmaceuticals, Inc. from 1999 to 2003, Principal at Eli Lilly & Co., and Vice President-Pharmacology & Business Development at Psychogenics, Inc. from 2003 to 2004.
Dr. Menzaghi received a doctorate from the University of Strasbourg and a graduate degree from Ecole des Mines de Nancy.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CARA THERAPEUTICS INC
0.31% | 2024-01-31 | 167,247 ( 0.31% ) | 152 195 $ | 2024-03-30 |
Former positions of Frèdèrique Menzaghi
| Companies | Position | End |
|---|---|---|
| CARA THERAPEUTICS, INC. | Founder | 2024-02-01 |
Psychogenics, Inc.
 Psychogenics, Inc. Pharmaceuticals: MajorHealth Technology Psychogenics, Inc. specializes in preclinical neurobiology solutions. It offers animal models, behavioral tests, histology/immunohistochemistry, microdialysis/bioanalysis, electrophysiology, molecular biology and pharmacology. The company was founded by Eric Nestler, Benjamin S. Bunney and Daniel Goodman and is headquartered in Paramus, NJ. | Corporate Officer/Principal | 2003-12-31 |
| ARENA PHARMACEUTICALS | Corporate Officer/Principal | 2002-12-31 |
| Sibia Neurosciences, Inc. | Founder | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Training of Frèdèrique Menzaghi
| University of Strasbourg | Doctorate Degree |
| Ecole des Mines de Nancy | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| CARA THERAPEUTICS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
| Sibia Neurosciences, Inc. | Health Technology |
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
Psychogenics, Inc.
Psychogenics, Inc. Pharmaceuticals: MajorHealth Technology Psychogenics, Inc. specializes in preclinical neurobiology solutions. It offers animal models, behavioral tests, histology/immunohistochemistry, microdialysis/bioanalysis, electrophysiology, molecular biology and pharmacology. The company was founded by Eric Nestler, Benjamin S. Bunney and Daniel Goodman and is headquartered in Paramus, NJ. | Health Technology |
- Stock Market
- Insiders
- Frèdèrique Menzaghi
